Cargando…

Development and characterization of an anti-rituximab monoclonal antibody panel

During the development of monoclonal antibodies (mAbs) and other therapeutic proteins, immunogenicity, in particular the induction of anti-drug antibodies (ADAs), is an important concern, and thus immunogenicity assessment is a requirement for their approval. Establishment of appropriate methods for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tada, Minoru, Suzuki, Takuo, Ishii-Watabe, Akiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916554/ https://www.ncbi.nlm.nih.gov/pubmed/29309213 http://dx.doi.org/10.1080/19420862.2018.1424610

Ejemplares similares

Development of a Cell-Based Assay Measuring the Activation of FcγRIIa for the Characterization of Therapeutic Monoclonal Antibodies
por: Tada, Minoru, et al.
Publicado: (2014)

Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex
por: Tada, Minoru, et al.
Publicado: (2023)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
por: Suzuki, Takuo, et al.
Publicado: (2021)

Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
por: Tada, Minoru, et al.
Publicado: (2015)

Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
por: Aoyama, Michihiko, et al.
Publicado: (2019)

Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments
por: Krayukhina, Elena, et al.
Publicado: (2017)

Establishment of a highly precise multi-attribute method for the characterization and quality control of therapeutic monoclonal antibodies
por: Tajiri-Tsukada, Michiko, et al.
Publicado: (2020)

Fcγ Receptor-Dependent Internalization and Off-Target Cytotoxicity of Antibody-Drug Conjugate Aggregates
por: Aoyama, Michihiko, et al.
Publicado: (2021)

Efficacy and safety evaluation of claudin‐4‐targeted antitumor therapy using a human and mouse cross‐reactive monoclonal antibody
por: Hashimoto, Yosuke, et al.
Publicado: (2016)

Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
por: Ladino, Marco, et al.
Publicado: (2009)

Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use
por: Stevens, Misty W, et al.
Publicado: (2014)

Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP
por: Lin, Ni-Hsuan, et al.
Publicado: (2017)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
por: Saffari, Fatemeh, et al.
Publicado: (2022)

Rituximab: Failed to develop anti-SARS-Cov-2 antibodies: case report
Publicado: (2021)

Case Report: Use of Obinutuzumab as an Alternative Monoclonal Anti-CD20 Antibody in a Patient With Refractory Immune Thrombocytopenia Complicated by Rituximab-Induced Serum Sickness and Anti-Rituximab Antibodies
por: Blase, Jennifer R., et al.
Publicado: (2022)

Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus
por: Gubbins, Michael J., et al.
Publicado: (2005)

Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab
por: Rabascall, Carlos X, et al.
Publicado: (2021)

Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design
por: Ogihara, Takuo, et al.
Publicado: (2023)

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas
por: Tsang, Kwong yok, et al.
Publicado: (2022)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
por: Ganesan, Rajkumar, et al.
Publicado: (2017)

Structural Characterization of the Full-Length Anti-CD20 Antibody Rituximab
por: Belviso, Benny Danilo, et al.
Publicado: (2022)

Characterization of a Panel of Cross-Reactive Hantavirus Nucleocapsid Protein-Specific Monoclonal Antibodies
por: Avižinienė, Aliona, et al.
Publicado: (2023)

Evaluation of the analytical performance of anti-SARS-CoV-2 antibody test kits distributed or developed in Japan
por: Shibata, Hiroko, et al.
Publicado: (2022)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Development and Characterization of Chimeric Anti‐carcinoembryonic Antigen Monoclonal Antibodies and Their Fab Fragments
por: Kamigaki, Takashi, et al.
Publicado: (1994)

Development and Characterization of New Species Cross-Reactive Anti-Sialoadhesin Monoclonal Antibodies
por: De Schryver, Marjorie, et al.
Publicado: (2016)

Humanization and Characterization of an Anti-Ricin Neutralization Monoclonal Antibody
por: Hu, Wei-Gang, et al.
Publicado: (2012)

Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies
por: Rahim, Md Niaz, et al.
Publicado: (2019)

Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor
por: Könitzer, Jennifer D., et al.
Publicado: (2017)

Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms
por: Bedinger, Daniel, et al.
Publicado: (2015)

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
por: Pierpont, Timothy M., et al.
Publicado: (2018)

Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
por: Li, Guanjie, et al.
Publicado: (2022)

Development and Characterization of Monoclonal Antibodies for the Mycotoxin Citreoviridin
por: Maragos, Chris M., et al.
Publicado: (2019)

Structural insight and stability of TNFR-Fc fusion protein (Etanercept) produced by using transgenic silkworms
por: Kiyoshi, Masato, et al.
Publicado: (2020)

Generation and Characterization of Anti-AA Amyloid-Specific Monoclonal Antibodies
por: Wall, Jonathan S., et al.
Publicado: (2011)

Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE
por: Kumagai, Akiko, et al.
Publicado: (2021)

Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus
por: Guo, Chun-yan, et al.
Publicado: (2015)

Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions
por: Krysko, Kristen M., et al.
Publicado: (2019)

Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
por: Papageorgiou, Sotirios G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jva0cuhg1jm7bt9oaf0rb8g92o